Valvular Heart Disease

  • Stephen D. PrestonEmail author


This chapter deals with current topics in valvular heart disease. Focusing on the most common types of diseased valve encountered in routine surgical practice including floppy mitral valves, degenerate tricuspid aortic valves and congenital bicuspid aortic valves. The pathology of infective endocarditis and rheumatic valvular heart disease is also discussed. Macroscopic and microscopic images of the different valve pathologies are provided as well as a detailed description of valve pathophysiology. The scientific data underlying the pathogenesis of the different forms of valvular heart disease is provided.


Stenosis Regurgitation Vegetation Calcification Rheumatic fever Congenital bicuspid valve Infective endocarditis Myxoid degeneration Aortic dilatation 


  1. 1.
    Filsoufi F, Carpentier A. Principles of reconstructive surgery in degenerative mitral valve disease. Semin Thorac Cardiovasc Surg. 2007;19:103–10.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Still WJS. Endocardial thickening associated with diseased valves. Br Heart J. 1961;23:155–61.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Coffey S, Harper AR, Cairns BJ, Roberts ISD, Prendergast BD. Clinical information has low sensitivity for postmortem diagnosis of heart valve diseases. Heart. 2017;103:1031–5.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Cherubin CE, Neu HC. Infective endocarditis at the Presbyterian Hospital in New York City. Am J Med. 1971;51:83–95.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Rabinovich S, Evans J, Smith IM, et al. A long-term view of bacterial endocarditis. Ann Intern Med. 1965;63:185–98.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Devereux RB, Frary CJ, Kramer-Fox R, et al. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol. 1994;74:1024–9.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Devereux RB, Brown WT, Kramer-Fox R, et al. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med. 1982;97:826–32.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Clemens JD, Horwitz RI, Jaffe CC, et al. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral valve prolapse. N Engl J Med. 1982;307:776–81.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82:681–8.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Hickey AJ, MacMahon SW, Wilcken DEL. Mitral valve prolapse and bacterial endocarditis: when is antibiotic prophylaxis necessary? Am Heart J. 1985;109:421–35.CrossRefGoogle Scholar
  11. 11.
    Danchin N, Voiriot P, Briancon S, et al. Mitral valve prolapse as a risk factor for infective endocarditis. Lancet. 1989;1:743–5.PubMedCrossRefGoogle Scholar
  12. 12.
    MacMahon SW, Hickey AJ, Wilcken DE, et al. Risk of infective endocarditis in mitral valve prolapse with and without precordial murmurs. Am J Cardiol. 1987;59:105–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Marks AR, Choong CY, Sanfilippo AJ, et al. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med. 1989;320:1031–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Varstela E, Verkkala K, Pohjola-Sintonen S, et al. Surgical treatment of infective aortic valve endocarditis. Scand J Thorac Cardiovasc Surg. 1991;25:167–74.PubMedCrossRefGoogle Scholar
  15. 15.
    Janatuinen MJ, Vanttinen EA, Nikoskelainen J, et al. Surgical treatment of active native endocarditis. Scand J Thorac Cardiovasc Surg. 1990;24:181–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Lamas CC, Ekyn SJ. Bicuspid aortic valve – a silent danger: analysis of 50 cases of infective endocarditis. Clin Infect Dis. 2000;30:336–41.PubMedCrossRefGoogle Scholar
  17. 17.
    Moulsdale MT, Eykyn SJ, Phillips I. Infective endocarditis 1970-1979. A study of culture-positive cases in St. Thomas Hospital. Q J Med. 1980;49:315–28.PubMedGoogle Scholar
  18. 18.
    Mugge A, Daniel WG, Frank G, et al. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14:631–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Freedman LR, Valone J Jr. Experimental infective endocarditis. Prog Cardiovasc Dis. 1979;22:169–80.PubMedCrossRefGoogle Scholar
  20. 20.
    Petersdorf RG, Pelletier LL, Durack DT. The 1976 Paul B. Beeson lecture. Some observations on experimental endocarditis. Yale J Biol Med. 1977;50:67–75.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Von Reyn CF, Levy BS, Arbeit RD, et al. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med. 1981;94:505–18.CrossRefGoogle Scholar
  22. 22.
    Brandão TJD, Januario-da-Silva CA, Correia MG, Zappa M, Abrantes JA, Dantas AMR, Golebiovski W, Barbosa GIF, Weksler C, Lamas CC. Histopathology of valves in infective endocarditis, diagnostic criteria and treatment consideration. Infection. 2017;45:199–207.PubMedCrossRefGoogle Scholar
  23. 23.
    Stone JR, Basso C, Baandrup UT, Bruneval P, Butany J, Gallagher PJ, Halushka MK, Miller DV, Padera RF, Radio SJ, Sheppard MN, Suvarna K, Tan CD, Thiene G, van der Wal AC, Veinot JP. Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology. Cardiovasc Pathol. 2012;21:2–16.PubMedCrossRefGoogle Scholar
  24. 24.
    Ringer M, Feen DJ, Drapkin M. Mitral valve prolapse: jet stream causing mural endocarditis. Am J Cardiol. 1980;45:383–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Kuhn C III, Weber N. Mural bacterial endocarditis of a ventricular friction lesion. Arch Pathol. 1973;95:92–3.PubMedGoogle Scholar
  26. 26.
    Lucas RV Jr, Edwards JE. The floppy mitral valve. Curr Probl Cardiol. 1982;7:1–48.PubMedCrossRefGoogle Scholar
  27. 27.
    Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1–142.PubMedCrossRefGoogle Scholar
  28. 28.
    El-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients; pathogenesis, diagnosis and treatment. Oncologist. 2007;12:518–23.PubMedCrossRefGoogle Scholar
  29. 29.
    Eiken PW, Edwards WD, Tazelaar HD, et al. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. Mayo Clin Proc. 2001;76:1204–12.PubMedCrossRefGoogle Scholar
  30. 30.
    Kim H, Suzuki M, Lie J, et al. Non-bacterial thrombotic endocarditis (NBTE) and disseminated intravascular coagulation (DIC). Arch Pathol Lab Med. 1977;101:65–8.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Olney B, Schattenberg T, Campbell J, et al. The consequences of the inconsequential: marantic (non-bacterial thrombotic) endocarditis. Am Heart J. 1979;98:513–22.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Hojnik M, George J, Ziporen L, et al. Heart valve involvement (Libman-Sacks Endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579–87.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Selzer A, Kohn KE. Natural history of mitral stenosis: a review. Circulation. 1972;45:878–90.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Abernathy WS, Willis PW III. Thromboembolic complications of rheumatic heart disease. Cardiovasc Clin. 1973;5:131–75.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Cabot RC. Facts on the Heart. Philadelphia, PA: W. B. Saunders Company; 1926.Google Scholar
  36. 36.
    Wood P. An appreciation of mitral stenosis, I: clinical features. Br Med J. 1954;4870:1051–63.CrossRefGoogle Scholar
  37. 37.
    Rowe JC, Bland EF, Sprague HB, et al. The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann Intern Med. 1960;52:741–9.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J. 1962;24:349–57.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Rusted IE, Schiefley CH, Edwards JE. Studies of the mitral valve, II: certain anatomic features of the mitral valve and associated structures in mitral stenosis. Circulation. 1956;14:398–406.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Gorlin R, Gorlin SG. Hydraulic formula for calcification of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J. 1951;41:1–29.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Roberts WC. Morphologic features of the normal and abnormal mitral valve. Am J Cardiol. 1983;51:1005–28.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;91:1220–5.CrossRefGoogle Scholar
  43. 43.
    Mohler ER III, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522–8.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    O’Brien KD, Reichenbach DD, Marcovina SM, et al. Apolipoproteins B (a), and E accumulate in the morphologically early lesion of “degenerative” valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996;16:523–32.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Olsson M, Dalsgaard CJ, Haegerstrand A, et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1994;23:1162–70.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol. 1987;59:998–9.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Mohler ER, Sheridan MJ, Nichols R, et al. Development and progression of aortic valve stenosis: atherosclerotic risk factors – a causal relationship? A clinical morphologic study. Clin Cardiol. 1991;14:995–9.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29:630–4.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Palta S, Pai AM, Gill KS, et al. New insights into the progression of aortic stenosis. Implications for secondary prevention. Circulation. 2000;101:2497–502.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Nassimiha D, Aronow WS, Ahn C. Association of coronary risk factors with progression of valvular aortic stenosis. Am J Cardiol. 2001;87:1313–4.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterisation of the early lesion of ‘degenerative’ valvular aortic stenosis; histological and immunohistochemical studies. Circulation. 1994;90:844–53.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Lindman BR, Clavel M-A, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Zhao Y, Nicoll R, He YH, Henein MY. The effects of statins on valve function and calcification in aortic stenosis: a meta-analysis. Atherosclerosis. 2016;246:318–24.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Kristen AV, Schnabel PA, Winter B, Helmke BM, Longerich T, Hardt S, Koch A, Sack F-U, Katus HA, Linke RP, Dengler TJ. High prevalence of amyloid in 150 surgically removed heart valves – a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions. Cardiovasc Pathol. 2010;19:228–35.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Audet A, Côté N, Couture C, Bossé Y, Després J-P, Pibarot P, Mathieu P. Amyloid substance within stenotic aortic valves promotes mineralization. Histopathology. 2012;61:610–9.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Kaden JJ, Dempfle CE, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodelling in calcific aortic valve stenosis. Cardiovasc Pathol. 2005;14:80–7.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Sprigings DC, Forfar JC. How should we manage symptomatic aortic stenosis in the patient who is 80 or older? Br Heart J. 1995;74:481–4.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(Suppl E):57–64.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–10.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Hein S, Arnon E, Kostin S, Schönberg M, Elsässer A, Polyakova V, Bauer EP, Klövekorn W-P, Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart; structural deterioration and compensatory mechanisms. Circulation. 2003;107:984–91.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101–11.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Braverman AC, Guven H. Beardslee at al. The bicuspid aortic valve. Curr Probl Cardiol. 2005;30:470–522.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55:2789–800.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998;101:E11.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Lopez-Rangel E, Maurice M, McGillivray B, et al. Williams syndrome in adults. Am J Med Genet. 1992;44:720–9.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Roos-Hesselink JW, Scholzel BE, et al. Aortic valve and aortic arch pathology after coarctation repair. Heart. 2003;89:1074–7.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Deshpande J, Kinare SG. The bicuspid aortic valve – an autopsy study. Indian J Pathol Microbiol. 1991;34:112–8.PubMedPubMedCentralGoogle Scholar
  69. 69.
    Suzuki T, Nagai R, Kurihara H, et al. Stenotic bicuspid aortic valve associated with a ventricular septal defect in an adult presenting with congestive heart failure: a rare observation. Eur Heart J. 1994;15:402–3.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Bolling SF, Iannattoni MD, Dick M II, et al. Shone’s anomaly: operative results and late outcome. Ann Thorac Surg. 1990;49:887–93.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270–4.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Huntington K, Hunter AG, Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol. 1997;30:1809–12.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Cripe L, Andelfinger G, Martin J, et al. Bicuspid aortic valve is heritable. J Am Coll Cardiol. 2004;44:138–43.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol. 2008;52:e1–121.CrossRefGoogle Scholar
  75. 75.
    Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970;26:72–83.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Fernandes SM, Khairy P, Sanders SP, et al. Bicuspid aortic valve morphology and interventions in the young. J Am Coll Cardiol. 2007;49:2211–4.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133:1226–33.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Sabet HY, Edwards WD, Tazelaar HD, et al. Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. Mayo Clin Proc. 1999;74:14–26.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Angelini A, Ho SY, Anderson RH, et al. The morphology of the normal aortic valve as compared with the aortic valve having two cusps. J Thorac Cardiovasc Surg. 1989;89:362–7.Google Scholar
  80. 80.
    Beppu S, Suzuki S, Matsuda H, et al. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am J Cardiol. 1993;71:322–7.PubMedCrossRefGoogle Scholar
  81. 81.
    Nigam V, Sievers HH, Jensen BC, Simpson PC, Srivastava D, Mohamed SA. Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves. J Heart Valve Dis. 2010;19:459–65.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Rajamannan NM. Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation. Cardiovasc Pathol. 2011;20:168–76.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Rabus MB, Kayalar N, Sareyyupoglu B, et al. Hypercholesterolaemia association with aortic stenosis of various etiologies. J Card Surg. 2009;24:146–50.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Yagubyan M, Sarkar G, Nishimura RA, et al. C-reactive protein as a marker of severe calcification among patients with bicuspid aortic valve disease. J Surg Res. 2004;121:281.CrossRefGoogle Scholar
  85. 85.
    Fedak PW, Verma S, David TE, et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation. 2002;106:900–4.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Pachulski RT, Weinberg AL, Chan KL. Aortic aneurysm in patients with functionally normal or minimally stenotic bicuspid aortic valve. Am J Cardiol. 1991;67:781–2.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Hahn RT, Roman MJ, Mogtader AH, et al. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol. 1992;19:283–8.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Edwards WD, Leaf DS, Edwards JE. Dissecting aortic aneurysm associated with congenital bicuspid aortic valve. Circulation. 1978;57:1022–5.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Roberts CS, Roberts WC. Dissection of the aorta associated with congenital malformation of the aortic valve. J Am Coll Cardiol. 1991;17:712–6.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Della Corte A, Bancone C, Quarto C, et al. Predictors of ascending aortic dilatation with bicuspid valve: a wide spectrum of disease expression. Eur J Cardiothrac Surg. 2007;31:397–405.CrossRefGoogle Scholar
  91. 91.
    Nistri S, Sorbo MD, Marin M, et al. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart. 1999;82:19–22.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol. 1984;53:849–55.PubMedCrossRefGoogle Scholar
  93. 93.
    Ergin MA, Spielvogel D, Apaydin A, et al. Surgical treatment of the descending dilated aorta: when and how? Ann Thorac Surg. 1999;67:1834–9.PubMedCrossRefGoogle Scholar
  94. 94.
    Morgan-Hughes GJ, Roobottom CA, Owens PE, et al. Dilatation of the aorta in pure, severe, bicuspid aortic valve stenosis. Am Heart J. 2004;147:736–40.PubMedCrossRefGoogle Scholar
  95. 95.
    McKusick VA. Association of congenital bicuspid aortic valve and Erdheim’s cystic medial necrosis. Lancet. 1972;1:1026–7.PubMedCrossRefGoogle Scholar
  96. 96.
    Niwa K, Perfloff JK, Bhuta SM, et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation. 2001;103:393–400.PubMedCrossRefGoogle Scholar
  97. 97.
    Bonderman D, Gharehbaghi-Schnell E, Wollenek G, et al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation. 1999;99:2138–43.PubMedCrossRefGoogle Scholar
  98. 98.
    Waters KM, Rooper LM, Guajardo A, Halushka MK. Histopathologic differences partially distinguish syndromic aortic diseases. Cardiovasc Pathol. 2017;30:6–11.PubMedCrossRefGoogle Scholar
  99. 99.
    Grewal N, Franken R, Mulder BJM, Goumans M-J, Lindeman JHN, Jongbloed MRM, DeRuiter MC, Klautz RJM, Bogers AJJC, Poelmann RE, Gittenberger-de Groot AC. Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy? Heart Vessels. 2016;31:795–806.PubMedCrossRefGoogle Scholar
  100. 100.
    Olson LJ, Subramanian R, Ackermann DM, et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc. 1987;62:22–34.PubMedCrossRefGoogle Scholar
  101. 101.
    Waller BF, Morrow AG, Maron BJ, et al. Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J. 1982;104:276–88.PubMedCrossRefGoogle Scholar
  102. 102.
    Freed LA, Acierno JS Jr, Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 2003;72:1551–9.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Read RC, Thal AP, Wendt VE. Symptomatic valvular myxomatous transformation (the floppy valve syndrome). A possible forme fruste of the Marfan syndrome. Circulation. 1965;32:897–910.PubMedCrossRefGoogle Scholar
  104. 104.
    Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med. 1999;341:1–7.PubMedCrossRefGoogle Scholar
  105. 105.
    Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 1999;65:1242–51.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Nesta F, Leyne M, Yosefy C, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation. 2005;112:2022–30.PubMedCrossRefGoogle Scholar
  107. 107.
    Kyndt F, Schott JJ, Trochu JN, et al. Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet. 1998;62:627–32.PubMedPubMedCentralCrossRefGoogle Scholar
  108. 108.
    Virmani R, Atkinson JB, Forman MB. The pathology of mitral valve prolapse. Herz. 1988;13:215–26.PubMedGoogle Scholar
  109. 109.
    Cole WG, Chan D, Hickey AJ, et al. Collagen composition of normal and myxomatous human mitral heart valves. Biochem J. 1984;219:451–60.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Tamura K, Fukuda Y, Ishizaki M, et al. Abnormalities in elastic fibres and other connective-tissue components of floppy mitral valve. Am Heart J. 1995;129:1149–58.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Olsen EG, Al-Rufaie HK. The floppy mitral valve: study on pathogenesis. Br Heart J. 1980;44:674–83.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Prunotto M, Primo Caimmi P, Bongiovanni M. Cellular pathology of mitral valve prolapse. Cardiovasc Pathol. 2010;19:e113–7.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Levine RA, Hagége AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, Beaudoin J, Bischoff J, Bouatia-Naji N, Bruneval P, Butcher JT, Carpentier A, Chaput M, Chester AH, Clusel C, Delling FN, Dietz HC, Dina C, Durst R, Fernandez-Friera L, Handschumacher MD, Jensen MO, Jeunmaitre XP, Le Marec H, Le Tourneau T, Markwald RR, Mérot J, Messas E, Milan DP, Neri T, Norris RA, Peal D, Perrocheau M, Probst V, Pucéat M, Rosenthal N, Solis J, Schott J-J, Schwammenthal E, Slaugenhaupt SA, Song J-K, Yacoub MH. Mitral valve disease – morphology and mechanisms. Nat Rev Cardiol. 2015;12:689–710.PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Fontana ME, Sparks EA, Boudoulas H, et al. Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol. 1991;16:309–75.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Grigioni F, Averinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002;40:84–92.PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Nalliah CJ, Mahajan R, Elliot AD, Haqqani H, Lau DH, Vohra JK, Morton JB, Semsarian C, Marwick T, Kalman JM, Sanders P. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart. 2019;105:144–51.PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani A, Chiara Frigo A, Rigato I, Migliore F, Pilichou K, Bertaglia E, Cacciavillani F, Bauce B, Corrado D, Thiene G, Ilceto S. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556–66.PubMedCrossRefPubMedCentralGoogle Scholar
  118. 118.
    Frescura C, Angelini A, Daliento L, Thiene G. Morphological aspects of Ebstein’s anomaly in adults. Thorac Cardiovasc Surg. 2000;48:203–8.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Attenhofer Jost CH, Tan NY, Hassan A, Vargas ER, Hodge DO, Dearani JA, Connolly H, Asirvatham SJ, McLeod CJ. Sudden death in patients with Ebstein anomaly. Eur Heart J. 2018;39:1970–7.PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation – part III. Clin Cardiol. 1995;18:225–30.PubMedCrossRefGoogle Scholar
  121. 121.
    Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation – part I. Clin Cardiol. 1995;19:97–102.CrossRefGoogle Scholar
  122. 122.
    Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation – Part II. Clin Cardiol. 1995;18:167–74.PubMedCrossRefPubMedCentralGoogle Scholar
  123. 123.
    Waller BF, Howard J, Fess S. Pathology of pulmonic valve stenosis and pure regurgitation. Clin Cardiol. 1995;18:45–50.PubMedCrossRefPubMedCentralGoogle Scholar
  124. 124.
    Altrichter PM, Olson LJ, Edwards WD, et al. Surgical pathology of the pulmonary valve: a study of 116 cases spanning 15 years. Mayo Clin Proc. 1989;64:1352–60.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Gujral DM, Lloyd G, Bhattacharyya S. Radiation induced valvular heart disease. Heart. 2016;102:269–76.PubMedCrossRefPubMedCentralGoogle Scholar
  126. 126.
    Nair V, Belanger EC, Veinot JP. Lysosomal storage disorders affecting the heart: a review. Cardiovasc Pathol. 2019;39:12–24.PubMedCrossRefPubMedCentralGoogle Scholar
  127. 127.
    Fesslová V, Corti P, Sersale G, Rovelli A, Russo P, Mannarino S, Butera G, Parini R. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young. 2009;19:170–8.PubMedCrossRefPubMedCentralGoogle Scholar
  128. 128.
    Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH. Cardiac valvular anomalies in Fabry disease: clinical, morphological, and biochemical studies. Circulation. 1976;54:818–25.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Royal Papworth Hospital NHS Foundation TrustCambridgeUK

Personalised recommendations